Pregabalin in generalized anxiety disorder: a placebo-controlled trial. - Wikidata - wikimedia - TriplyDB

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

http://www.wikidata.org/entity/Q44336408

about

Pregabalin for the treatment of generalized anxiety disorder: an update The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic Emerging drugs for the treatment of anxiety Anxioselective anxiolytics: on a quest for the Holy Grail The effectiveness of anticonvulsants in psychiatric disorders Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorder.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Psychometric evaluation of a visual analog scale for the assessment of anxiety.Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Pregabalin in acute and chronic pain.Pregabalin for the treatment of generalized anxiety disorder.Generalized anxiety disorder: acute and chronic treatment.Pregabalin: a review of its use in adults with generalized anxiety disorder.Pharmacological treatment for generalized anxiety disorder in adults: an update.Abuse Potential of Pregabalin: A Systematic Review.Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.Pregabalin influences insula and amygdala activation during anticipation of emotional images.Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.Comorbidities in chronic neuropathic pain.Pregabalin effects on neural response to emotional faces.Comprehensive care of the epilepsy patient--control, comorbidity, and cost.Treatments for generalized anxiety disorder.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Pregabalin: a new neuromodulator with broad therapeutic indications.Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders.Diagnosis and Treatment Procedures for Patients With Anxiety Disorders by the Psychiatric Consultation Liaison Service in a General Hospital in Germany: A Retrospective Analysis Pregabalin for the treatment of generalised anxiety disorder.Effects of antiepileptic drugs on mood and behavior.Pregabalin for pain management.A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal.The diagnosis and treatment of generalized anxiety disorder.Role of pregabalin in the treatment of generalized anxiety disorder Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)Predictors of premature discontinuation of treatment in multiple disease states Does pregabalin have neuropsychotropic effects?: a short perspective.Advances in pharmacotherapy for pediatric anxiety disorders.

P2860

Q24604809-FBE05D46-8EEC-487E-A6D6-5BDD3318B769 Q24658278-98D00A36-2A7C-44F5-8199-AAF63EA468C3 Q28083141-8C59E66A-FB03-4EF8-8126-1C6F1BEB19A0 Q28275122-5379967D-F777-42D8-A317-1BB3A236B431 Q28744504-44B10050-9BDD-4DFE-854D-41A277B45F82 Q28972575-847F6691-F86F-4DE4-8FC7-B27EA9DA37A2 Q33642622-E3997698-65AA-437B-BC89-3366DB056904 Q33949565-D05544D2-C59F-494A-902D-923212495C16 Q33997934-43C0EA50-94C0-410A-93D8-D228041B03A0 Q34024109-CD1DC298-9127-4421-8A23-13B40A47C93F Q34183517-A1610C55-D5EB-4C99-94FB-22093BCBF329 Q34214071-202E6379-BD84-4C0D-95F9-093154B9D00E Q34259185-C9F9602D-4A1D-4781-A40B-4098354625BF Q34353112-FC263446-2250-4EFC-A166-6FE93AD28355 Q34434641-0D80883C-2A76-44F6-88F0-D2CA52F9E17C Q34484276-FF03EE6F-8706-4AA5-AD26-CF6704779172 Q34509031-B89962A8-88D7-48DE-B2AD-D20C063118FE Q34645876-6A208870-CE02-4E0F-A8FA-9F2035675595 Q34865036-BBBD0E6F-42D9-4BB7-977D-FF677A9B43A4 Q34988442-99BEBE94-CEE2-4147-9E50-AB6E3915A654 Q35021417-20981675-9DBC-48E4-9D65-F07BE4A61944 Q35252034-C167E1F5-3A38-442E-8741-E8C5F4A0A554 Q35680402-EF7E5990-9B4A-49B8-ADDC-2A3F09255DDF Q35855502-E5D0D78E-00D9-4E28-9354-A00752224FD5 Q35865168-1C87EA04-FE71-4AFC-90DE-03CAF1F6B8E4 Q36107118-CDDB9B74-0A8D-4C8F-BB0D-3F0B61DC61F9 Q36199036-45F790D3-9D9F-40E1-A881-A9D81E1BCCAC Q36313119-ECE26A20-81C3-436E-A564-652B0D66CA7B Q36403889-CEE6EB5E-A2A9-457E-940E-72BF32A4E66A Q36518659-697F416E-AB54-49AC-A8C5-B816F7F01BE0 Q36613951-47C609DA-F4B1-498E-AA79-230D3424E445 Q36653769-1B7BE26E-39AA-44EE-BF6C-F4E375A05EA1 Q36687433-BABDC6ED-AE85-4F22-B4EC-5EC4A9D9A770 Q36797810-7924DBE5-B3C3-4352-89C4-753381FBD750 Q36837462-FB04A133-8E26-4ABD-90E6-0539CECC9AA2 Q37125739-DD3C7D2C-442F-4619-AB44-ED91D3FD795B Q37242260-1F6F2CAE-8D99-44D0-A0E2-D34A78E51FEC Q37423705-DACC91AA-0130-4800-8C4C-2E93BB7DE263 Q37484092-6B9ED053-B66B-4C7D-88F1-4B6F06071BB7 Q37827822-CAA8C62A-BAAE-48A1-BAE5-32E9E3766AB7

P2860

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

http://www.wikidata.org/entity/Q44336408

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@en

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@nl

type

label

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@en

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@nl

prefLabel

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@en

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@nl

P1433

Q44336408-F85C0C1A-1264-4ABF-AF33-1A5E9F4B6E3F

P1476

Q44336408-BC729818-6787-4A85-B72A-38BF96ABFAA0

P2093

Q44336408-2DC958E8-B492-47D1-B2AD-18DAEDCE2738

Q44336408-790F1117-D5AF-443B-B3EF-AB3D150A2247

Q44336408-79A4BBAF-C4A9-4411-B84E-0A5BFD78A5A4

Q44336408-93E0D5B9-53CA-442F-9363-39D59C1B69A4

Q44336408-9845D1C2-C39A-473E-BE65-0DC395E3B492

Q44336408-9C5EF45F-C5CC-46BF-8C14-DD01D5DBBDC2

Q44336408-C6B70719-FBBC-4A44-ADB3-997078366426

Q44336408-C929B647-0B47-4DC7-8094-5CAE63246A58

Q44336408-D6F8E969-808E-4D46-A67F-B6F3AEE27A6B

Q44336408-E26774DA-E9E2-4B48-9A52-D59C3C32B9FB

P304

Q44336408-68F1D1D3-806A-4B98-B260-70E68BBB807C

P31

Q44336408-F0CB37D4-D64C-4F71-90C0-CBCF1F48A834

P356

Q44336408-FEC58469-12CB-4104-9718-D968CFB694A2

P407

Q44336408-225BCA91-4540-4B3B-8762-CFE7C3646C9A

P433

Q44336408-79140674-C8F6-4840-85D7-A3D9BF78989C

P478

Q44336408-4DCF7F7D-036B-44FB-974B-8A5E7F27C839

P577

Q44336408-8C676552-9C3A-433F-B20F-DCCB8C7892EB

P5875

Q44336408-E3E3B700-B69C-411E-8ED2-6C667536F82C

P698

Q44336408-578F02D5-DBCD-4564-97B4-3C6087CE0517

P921

Q44336408-C557B309-B70C-4A58-A216-2A3873D8213C

P356

APPI.AJP.160.3.533

P1433

American Journal of Psychiatry

P1476

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

@en

P2093

Atul C Pande

http://www.w3.org/2001/XMLSchema#string

Carol A Janney

http://www.w3.org/2001/XMLSchema#string

Dan L Zimbroff

http://www.w3.org/2001/XMLSchema#string

Douglas E Feltner

http://www.w3.org/2001/XMLSchema#string

Jerri G Crockatt

http://www.w3.org/2001/XMLSchema#string

Jonathan R T Davidson

http://www.w3.org/2001/XMLSchema#string

Maria Liu-Dumaw

http://www.w3.org/2001/XMLSchema#string

Peter D Londborg

http://www.w3.org/2001/XMLSchema#string

Richard Weisler

http://www.w3.org/2001/XMLSchema#string

Robert J Bielski

http://www.w3.org/2001/XMLSchema#string

P304

533-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.160.3.533

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10878119

http://www.w3.org/2001/XMLSchema#string

P698

12611835

http://www.w3.org/2001/XMLSchema#string

P921